Merck (BUE:MRK) Total Stockholders Equity : ARS13,566,741 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Merck Total Stockholders Equity?

Merck's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ARS13,566,741 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Merck's Book Value per Share for the quarter that ended in Dec. 2023 was ARS53,588.96. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Merck's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.93.

Merck Total Stockholders Equity Historical Data

The historical data trend for Merck's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Total Stockholders Equity Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,548,554.65

2,060,297.39

3,856,202.08

7,710,390.94

13,566,741.01

Merck Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															7,710,390.94	9,252,056.92	9,286,319.93	14,434,038.10	13,566,741.01

Merck (BUE:MRK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Merck's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(13566741.012	-	0)	/	253.163
	=	53,588.96

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Merck's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(495292	+	12159563.011)	/	13566741.012
	=	0.93

Merck Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Merck's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck (BUE:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BUE:MRK) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.